Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (1693)	11/15/1998 2:06:00 PM
From: Rudy Saucillo	Read Replies (2) \| Respond to of 2742

BSTC sales for the quarter ending 4/30/98 increased 42% over sales from the quarter ending 4/30/97; sales from the quarter ending 7/31/98 were up 51% from the comparable 1997 quarter. BSTC recently signed a co-marketing agreement with a J&J company (Ortho) which will expand sales into the diabetic foot ulcer market. This, IMO, is an aggressive, growing company. But I don't mean to imply it's an ideal fit with Cistron. In general look for small to medium-sized companies that have earnings growth, complementary business with Cistron, and which need cash to expand activities. Rudy